## **Core Concept**
The question tests the understanding of tocolytic agents used in managing preterm labor and their side effects, particularly the association with pulmonary edema. Tocolytic agents are drugs used to suppress premature uterine contractions. The key here is to identify which tocolytic agent is most commonly associated with pulmonary edema.

## **Why the Correct Answer is Right**
The correct answer, **ritodrine**, is a beta-2 adrenergic agonist. Beta-2 agonists, like ritodrine, are known to cause fluid retention and can lead to pulmonary edema as a side effect. This is because they can cause an increase in vascular permeability and fluid shifts, leading to pulmonary edema, especially in the context of fluid overload or when used in conjunction with corticosteroids.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Not specified, but assuming it's another tocolytic agent not commonly associated with pulmonary edema.
- **Option B:** If this option is **nifedipine**, a calcium channel blocker, it's less likely to cause pulmonary edema directly compared to beta-2 agonists. Nifedipine works by relaxing the smooth muscle of the uterus and is not commonly associated with pulmonary edema.
- **Option C:** If this option is **indomethacin**, a nonsteroidal anti-inflammatory drug (NSAID), it's not typically associated with pulmonary edema. Indomethacin works by inhibiting prostaglandin synthesis, which plays a role in uterine contractions.
- **Option D:** Not specified, but assuming it's another agent less likely associated with pulmonary edema.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **beta-2 agonists**, such as **ritodrine**, are associated with maternal side effects including **pulmonary edema**, fluid retention, and tachycardia. Clinicians must carefully monitor patients on these agents for signs of fluid overload.

## **Correct Answer:** .